Study of Venetoclax Plus DA-EPOCH-R for the Treatment of Aggressive B-Cell Lymphomas

Clinical trial NCT03036904 · COMPLETED

Trial details

NCT number

NCT03036904

Sponsor

Weill Medical College of Cornell University

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2017-02-06

Primary completion

2021-11-11

Enrollment

31

View on ClinicalTrials.gov